Induced pluripotent stem cell technology: a decade of progress
暂无分享,去创建一个
Shinya Yamanaka | Haruhisa Inoue | Yanhong Shi | S. Yamanaka | Yanhong Shi | Joseph C. Wu | H. Inoue
[1] Krishanu Saha,et al. Establishment of Reporter Lines for Detecting Fragile X Mental Retardation (FMR1) Gene Reactivation in Human Neural Cells , 2017, Stem cells.
[2] Evgenios Neofytou,et al. Potential Strategies to Address the Major Clinical Barriers Facing Stem Cell Regenerative Therapy for Cardiovascular Disease: A Review. , 2016, JAMA cardiology.
[3] Michael P Snyder,et al. Transcriptome Profiling of Patient-Specific Human iPSC-Cardiomyocytes Predicts Individual Drug Safety and Efficacy Responses In Vitro. , 2016, Cell stem cell.
[4] Yusuke Inoue,et al. Current Public Support for Human-Animal Chimera Research in Japan Is Limited, Despite High Levels of Scientific Approval. , 2016, Cell stem cell.
[5] T. Townes,et al. Novel HDAd/EBV Reprogramming Vector and Highly Efficient Ad/CRISPR-Cas Sickle Cell Disease Gene Correction , 2016, Scientific Reports.
[6] Zayd M. Khaliq,et al. A New Glucocerebrosidase Chaperone Reduces α-Synuclein and Glycolipid Levels in iPSC-Derived Dopaminergic Neurons from Patients with Gaucher Disease and Parkinsonism , 2016, The Journal of Neuroscience.
[7] Mackenzie W. Mathis,et al. ALS disrupts spinal motor neuron maturation and aging pathways within gene co-expression networks , 2016, Nature Neuroscience.
[8] A. Riggs,et al. Small-Molecule-Based Lineage Reprogramming Creates Functional Astrocytes , 2016, Cell reports.
[9] F. Gage,et al. Functional Implications of miR-19 in the Migration of Newborn Neurons in the Adult Brain , 2016, Neuron.
[10] F. Gage,et al. Evaluating cell reprogramming, differentiation and conversion technologies in neuroscience , 2016, Nature Reviews Neuroscience.
[11] G. Gintant,et al. Evolution of strategies to improve preclinical cardiac safety testing , 2016, Nature Reviews Drug Discovery.
[12] Megan Scudellari. How iPS cells changed the world , 2016, Nature.
[13] David W. Nauen,et al. Brain-Region-Specific Organoids Using Mini-bioreactors for Modeling ZIKV Exposure , 2016, Cell.
[14] P. Garcez,et al. Zika virus impairs growth in human neurospheres and brain organoids , 2016, Science.
[15] Amadou A. Sall,et al. The Brazilian Zika virus strain causes birth defects in experimental models , 2016, Nature.
[16] M. Deleidi,et al. Genome editing in pluripotent stem cells: research and therapeutic applications. , 2016, Biochemical and biophysical research communications.
[17] R. Jaenisch,et al. Induced Pluripotent Stem Cells Meet Genome Editing. , 2016, Cell stem cell.
[18] Marc Tessier-Lavigne,et al. Efficient introduction of specific homozygous and heterozygous mutations using CRISPR/Cas9 , 2016, Nature.
[19] J. Rapoport,et al. Dysregulation of miRNA-9 in a Subset of Schizophrenia Patient-Derived Neural Progenitor Cells. , 2016, Cell reports.
[20] M. Dehouck,et al. Stem Cell-Based Human Blood-Brain Barrier Models for Drug Discovery and Delivery. , 2016, Trends in biotechnology.
[21] Jason R Spence,et al. Organoid Models of Human Gastrointestinal Development and Disease. , 2016, Gastroenterology.
[22] Nazish Sayed,et al. Translation of Human-Induced Pluripotent Stem Cells: From Clinical Trial in a Dish to Precision Medicine. , 2016, Journal of the American College of Cardiology.
[23] R. W. Hansen,et al. Journal of Health Economics , 2016 .
[24] David R. Liu,et al. Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage , 2016, Nature.
[25] Nevan J Krogan,et al. CRISPR Interference Efficiently Induces Specific and Reversible Gene Silencing in Human iPSCs. , 2016, Cell stem cell.
[26] F. Gage,et al. 2D and 3D Stem Cell Models of Primate Cortical Development Identify Species-Specific Differences in Progenitor Behavior Contributing to Brain Size , 2016, Cell stem cell.
[27] Yonatan Stelzer,et al. Parkinson-associated risk variant in enhancer element produces subtle effect on target gene expression , 2016, Nature.
[28] G. Howell,et al. Toward more predictive genetic mouse models of Alzheimer's disease , 2016, Brain Research Bulletin.
[29] Giulia Fragola,et al. Identification of chemicals that mimic transcriptional changes associated with autism, brain aging and neurodegeneration , 2016, Nature Communications.
[30] A. Riggs,et al. The TLX-miR-219 cascade regulates neural stem cell proliferation in neurodevelopment and schizophrenia iPSC model , 2016, Nature Communications.
[31] A. Trounson,et al. Pluripotent stem cells progressing to the clinic , 2016, Nature Reviews Molecular Cell Biology.
[32] S. Yamanaka,et al. A decade of transcription factor-mediated reprogramming to pluripotency , 2016, Nature Reviews Molecular Cell Biology.
[33] N. Benvenisty,et al. Pluripotent stem cells in disease modelling and drug discovery , 2016, Nature Reviews Molecular Cell Biology.
[34] Nick Barker,et al. Organoids as an in vitro model of human development and disease , 2016, Nature Cell Biology.
[35] A. Hyman,et al. CPAP promotes timely cilium disassembly to maintain neural progenitor pool , 2016, The EMBO journal.
[36] J. C. Love,et al. Single-Cell Detection of Secreted Aβ and sAPPα from Human IPSC-Derived Neurons and Astrocytes , 2016, The Journal of Neuroscience.
[37] Praveen Shukla,et al. Engineered heart tissues and induced pluripotent stem cells: Macro- and microstructures for disease modeling, drug screening, and translational studies. , 2016, Advanced drug delivery reviews.
[38] M. Eiraku,et al. Functional anterior pituitary generated in self-organizing culture of human embryonic stem cells , 2016, Nature Communications.
[39] A. Connolly,et al. Comparison of Magnetic Resonance Imaging and Serum Biomarkers for Detection of Human Pluripotent Stem Cell-Derived Teratomas , 2016, Stem Cell Reports.
[40] Jeffrey M Karp,et al. Engineering Stem Cell Organoids. , 2016, Cell stem cell.
[41] F. Pereyra-Bonnet,et al. iPSCs: A Minireview from Bench to Bed, including Organoids and the CRISPR System , 2016, Stem cells international.
[42] David A. Scott,et al. Rationally engineered Cas9 nucleases with improved specificity , 2015, Science.
[43] K. Eggan,et al. 10 Questions: Clinical Outlook for iPSCs. , 2016, Cell stem cell.
[44] Lei S. Qi,et al. Beyond editing: repurposing CRISPR–Cas9 for precision genome regulation and interrogation , 2016, Nature Reviews Molecular Cell Biology.
[45] Madeline A. Lancaster,et al. Human cerebral organoids recapitulate gene expression programs of fetal neocortex development , 2015, Proceedings of the National Academy of Sciences.
[46] Jürgen Winkler,et al. Directly Reprogrammed Human Neurons Retain Aging-Associated Transcriptomic Signatures and Reveal Age-Related Nucleocytoplasmic Defects. , 2015, Cell stem cell.
[47] S. Yamanaka,et al. From Genomics to Gene Therapy: Induced Pluripotent Stem Cells Meet Genome Editing. , 2015, Annual review of genetics.
[48] Jian Xu,et al. Induced Pluripotency and Gene Editing in Disease Modelling: Perspectives and Challenges , 2015, International journal of molecular sciences.
[49] Yoshiki Sasai,et al. Generation of functional hippocampal neurons from self-organizing human embryonic stem cell-derived dorsomedial telencephalic tissue , 2015, Nature Communications.
[50] J. Nurnberger,et al. Differential responses to lithium in hyperexcitable neurons from patients with bipolar disorder , 2015, Nature.
[51] Beau R. Webber,et al. In Vitro T‐Cell Generation From Adult, Embryonic, and Induced Pluripotent Stem Cells: Many Roads to One Destination , 2015, Stem cells.
[52] Huan Wang,et al. Transdifferentiation via transcription factors or microRNAs: Current status and perspective. , 2015, Differentiation; research in biological diversity.
[53] A. Consiglio,et al. Aberrant epigenome in iPSC‐derived dopaminergic neurons from Parkinson's disease patients , 2015, EMBO molecular medicine.
[54] S. Lopes,et al. Kidney organoids from human iPS cells contain multiple lineages and model human nephrogenesis , 2015, Nature.
[55] Robert Lanza,et al. Current status of pluripotent stem cells: moving the first therapies to the clinic , 2015, Nature Reviews Drug Discovery.
[56] C. David Page,et al. Human pluripotent stem cell-derived neural constructs for predicting neural toxicity , 2015, Proceedings of the National Academy of Sciences.
[57] Bon-Kyoung Koo,et al. Modeling mouse and human development using organoid cultures , 2015, Development.
[58] Chia-wei Chang,et al. Modeling Human Severe Combined Immunodeficiency and Correction by CRISPR/Cas9-Enhanced Gene Targeting. , 2015, Cell reports.
[59] D. Clegg,et al. Humanized Mice Reveal Differential Immunogenicity of Cells Derived from Autologous Induced Pluripotent Stem Cells. , 2015, Cell stem cell.
[60] F. Gage,et al. Functional Gene Correction for Cystic Fibrosis in Lung Epithelial Cells Generated from Patient iPSCs. , 2015, Cell reports.
[61] Yusheng Qu,et al. Proarrhythmia Risk Assessment in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes Using the Maestro MEA Platform. , 2015, Toxicological sciences : an official journal of the Society of Toxicology.
[62] Asher Mullard. Stem-cell discovery platforms yield first clinical candidates , 2015, Nature Reviews Drug Discovery.
[63] N. Fujii,et al. Early pathogenesis of Duchenne muscular dystrophy modelled in patient-derived human induced pluripotent stem cells , 2015, Scientific Reports.
[64] E. Tartour,et al. Human embryonic stem cell-derived cardiac progenitors for severe heart failure treatment: first clinical case report. , 2015, European heart journal.
[65] Jin-Soo Kim,et al. Functional Correction of Large Factor VIII Gene Chromosomal Inversions in Hemophilia A Patient-Derived iPSCs Using CRISPR-Cas9. , 2015, Cell stem cell.
[66] R. Jaenisch,et al. Corrigendum: Parkinson-causing α-synuclein missense mutations shift native tetramers to monomers as a mechanism for disease initiation , 2015, Nature Communications.
[67] M. Gerstein,et al. FOXG1-Dependent Dysregulation of GABA/Glutamate Neuron Differentiation in Autism Spectrum Disorders , 2015, Cell.
[68] Shinichiro Ogawa,et al. Directed differentiation of cholangiocytes from human pluripotent stem cells , 2015, Nature Biotechnology.
[69] T. Karlsen,et al. Cholangiocytes derived from human induced pluripotent stem cells for disease modeling and drug validation , 2015, Nature Biotechnology.
[70] Kevin Eggan,et al. From Dish to Bedside: Lessons Learned While Translating Findings from a Stem Cell Model of Disease to a Clinical Trial. , 2015, Cell stem cell.
[71] Wenwei Huang,et al. High‐Throughput Screening to Identify Compounds That Increase Fragile X Mental Retardation Protein Expression in Neural Stem Cells Differentiated From Fragile X Syndrome Patient‐Derived Induced Pluripotent Stem Cells , 2015, Stem cells translational medicine.
[72] Larry A Couture,et al. Hurdles to clinical translation of human induced pluripotent stem cells. , 2015, The Journal of clinical investigation.
[73] D. Geschwind,et al. Functional cortical neurons and astrocytes from human pluripotent stem cells in 3D culture , 2015, Nature Methods.
[74] P. Loria,et al. Developing predictive assays: The phenotypic screening “rule of 3” , 2015, Science Translational Medicine.
[75] A. Palmeri,et al. Rodent models for Alzheimer’s disease drug discovery , 2015, Expert opinion on drug discovery.
[76] Shinya Yamanaka,et al. Efficient Detection and Purification of Cell Populations Using Synthetic MicroRNA Switches. , 2015, Cell stem cell.
[77] Elsa Vera,et al. Programming and Reprogramming Cellular Age in the Era of Induced Pluripotency. , 2015, Cell stem cell.
[78] T. Bouwmeester,et al. High-Throughput Screening Using iPSC-Derived Neuronal Progenitors to Identify Compounds Counteracting Epigenetic Gene Silencing in Fragile X Syndrome , 2015, Journal of biomolecular screening.
[79] Jerry Avorn,et al. The $2.6 billion pill--methodologic and policy considerations. , 2015, The New England journal of medicine.
[80] K. Blennow,et al. APP Metabolism Regulates Tau Proteostasis in Human Cerebral Cortex Neurons , 2015, Cell reports.
[81] F. Gage,et al. Neuronal medium that supports basic synaptic functions and activity of human neurons in vitro , 2015, Proceedings of the National Academy of Sciences.
[82] Steven D. Edland,et al. Elucidating molecular phenotypes caused by the SORL1 Alzheimer's disease genetic risk factor using human induced pluripotent stem cells. , 2015, Cell stem cell.
[83] M. Rao,et al. Mitochondrial Alterations by PARKIN in Dopaminergic Neurons Using PARK2 Patient-Specific and PARK2 Knockout Isogenic iPSC Lines , 2015, Stem cell reports.
[84] Gail H Deutsch,et al. In vitro generation of human pluripotent stem cell derived lung organoids , 2015, eLife.
[85] James Adjaye,et al. Induced pluripotent stem cell-derived neuronal cells from a sporadic Alzheimer’s disease donor as a model for investigating AD-associated gene regulatory networks , 2015, BMC Genomics.
[86] Hideshi Kawakami,et al. Self-organization of polarized cerebellar tissue in 3D culture of human pluripotent stem cells. , 2015, Cell reports.
[87] G. Parry,et al. Human secreted tau increases amyloid-beta production , 2015, Neurobiology of Aging.
[88] J. D. Foster,et al. Human iPSC-derived motoneurons harbouring TARDBP or C9ORF72 ALS mutations are dysfunctional despite maintaining viability , 2015, Nature Communications.
[89] S. Ge,et al. Parkin Mutations Reduce the Complexity of Neuronal Processes in iPSC‐Derived Human Neurons , 2015, Stem cells.
[90] F. Gage,et al. Phenotypic differences in hiPSC NPCs derived from patients with schizophrenia , 2014, Molecular Psychiatry.
[91] C. Bravery. Do human leukocyte antigen-typed cellular therapeutics based on induced pluripotent stem cells make commercial sense? , 2015, Stem cells and development.
[92] Rudolph E. Tanzi,et al. Effect of potent γ-secretase modulator in human neurons derived from multiple presenilin 1-induced pluripotent stem cell mutant carriers. , 2014, JAMA neurology.
[93] David W. Nauen,et al. Synaptic dysregulation in a human iPS cell model of mental disorders , 2014, Nature.
[94] Eric E Schadt,et al. iPSC-derived dopamine neurons reveal differences between monozygotic twins discordant for Parkinson's disease. , 2014, Cell reports.
[95] Ying Sun,et al. An in vivo model of human small intestine using pluripotent stem cells , 2014, Nature Medicine.
[96] S. Ikegawa,et al. Statin treatment rescues FGFR3 skeletal dysplasia phenotypes , 2014, Nature.
[97] Carlos Cruchaga,et al. Identification of rare variants in Alzheimer’s disease , 2014, Front. Genet..
[98] Michael Schumacher,et al. Modeling human development and disease in pluripotent stem cell-derived gastric organoids , 2014, Nature.
[99] Anirvan Ghosh,et al. SMN2 splicing modifiers improve motor function and longevity in mice with spinal muscular atrophy , 2014, Science.
[100] H. Nakauchi,et al. Acid sphingomyelinase modulates the autophagic process by controlling lysosomal biogenesis in Alzheimer's disease , 2014 .
[101] Juergen A. Knoblich,et al. Organogenesis in a dish: Modeling development and disease using organoid technologies , 2014, Science.
[102] Elias T. Zambidis,et al. Induced pluripotent stem cells from familial Alzheimer's disease patients differentiate into mature neurons with amyloidogenic properties. , 2014, Stem cells and development.
[103] Kun Zhang,et al. Whole-genome sequencing analysis reveals high specificity of CRISPR/Cas9 and TALEN-based genome editing in human iPSCs. , 2014, Cell stem cell.
[104] David W. Nauen,et al. Modeling a genetic risk for schizophrenia in iPSCs and mice reveals neural stem cell deficits associated with adherens junctions and polarity. , 2014, Cell stem cell.
[105] Chad A. Cowan,et al. Low incidence of off-target mutations in individual CRISPR-Cas9 and TALEN targeted human stem cell clones detected by whole-genome sequencing. , 2014, Cell stem cell.
[106] D. Selkoe,et al. The familial Alzheimer's disease APPV717I mutation alters APP processing and Tau expression in iPSC-derived neurons. , 2014, Human molecular genetics.
[107] S. Gygi,et al. iPSC-derived neurons from GBA1-associated Parkinson’s disease patients show autophagic defects and impaired calcium homeostasis , 2014, Nature Communications.
[108] H. Goodridge. Induced pluripotent stem cell-derived myeloid phagocytes: disease modeling and therapeutic applications. , 2014, Drug discovery today.
[109] Daniel T. Montoro,et al. Transplanted Terminally Differentiated Induced Pluripotent Stem Cells Are Accepted By Immune Mechanisms Similar To Self-Tolerance , 2014, Nature Communications.
[110] Christine A. Wells,et al. Single-Cell Gene Expression Profiles Define Self-Renewing, Pluripotent, and Lineage Primed States of Human Pluripotent Stem Cells , 2014, Stem cell reports.
[111] Robert H. Brown,et al. Intrinsic membrane hyperexcitability of amyotrophic lateral sclerosis patient-derived motor neurons. , 2014, Cell reports.
[112] Chunhui Xu,et al. In vitro organogenesis from pluripotent stem cells , 2014, Organogenesis.
[113] K. Sekiguchi,et al. Isolation of Human Induced Pluripotent Stem Cell-Derived Dopaminergic Progenitors by Cell Sorting for Successful Transplantation , 2014, Stem cell reports.
[114] Shinya Yamanaka,et al. iPS cells: a game changer for future medicine , 2014, The EMBO journal.
[115] Yilong Li,et al. Genome-wide recessive genetic screening in mammalian cells with a lentiviral CRISPR-guide RNA library , 2013, Nature Biotechnology.
[116] Richard Wade-Martins,et al. Physiological Characterisation of Human iPS-Derived Dopaminergic Neurons , 2014, PloS one.
[117] Nobutaka Hattori,et al. Cerebral organoids model human brain development and microcephaly , 2014, Movement disorders : official journal of the Movement Disorder Society.
[118] A. Robin,et al. Duplication of TBK1 Stimulates Autophagy in iPSC-derived Retinal Cells from a Patient with Normal Tension Glaucoma , 2014, Journal of stem cell research & therapy.
[119] Jin-Soo Kim,et al. Cas-OFFinder: a fast and versatile algorithm that searches for potential off-target sites of Cas9 RNA-guided endonucleases , 2014, Bioinform..
[120] G. Pan,et al. Neural progenitor cells from human induced pluripotent stem cells generated less autogenous immune response , 2014, Science China Life Sciences.
[121] Neville E. Sanjana,et al. Genome-Scale CRISPR-Cas9 Knockout Screening in Human Cells , 2014, Science.
[122] J. Kessler,et al. Stem cell derived basal forebrain cholinergic neurons from Alzheimer’s disease patients are more susceptible to cell death , 2014, Molecular Neurodegeneration.
[123] Luke A. Gilbert,et al. Dynamic Imaging of Genomic Loci in Living Human Cells by an Optimized CRISPR/Cas System , 2013, Cell.
[124] D. Krainc,et al. Human iPSC-based modeling of late-onset disease via progerin-induced aging. , 2013, Cell stem cell.
[125] J. Mertens,et al. APP Processing in Human Pluripotent Stem Cell-Derived Neurons Is Resistant to NSAID-Based γ-Secretase Modulation , 2013, Stem cell reports.
[126] John R. Yates,et al. Isogenic Human iPSC Parkinson’s Model Shows Nitrosative Stress-Induced Dysfunction in MEF2-PGC1α Transcription , 2013, Cell.
[127] Kun Zhang,et al. The presenilin-1 ΔE9 mutation results in reduced γ-secretase activity, but not total loss of PS1 function, in isogenic human stem cells. , 2013, Cell reports.
[128] M. Eiraku,et al. Self-organization of axial polarity, inside-out layer pattern, and species-specific progenitor dynamics in human ES cell–derived neocortex , 2013, Proceedings of the National Academy of Sciences.
[129] T. Ichisaka,et al. Differentiation-defective phenotypes revealed by large-scale analyses of human pluripotent stem cells , 2013, Proceedings of the National Academy of Sciences.
[130] David A. Scott,et al. Double Nicking by RNA-Guided CRISPR Cas9 for Enhanced Genome Editing Specificity , 2013, Cell.
[131] James W Kramer,et al. Multi-parameter in vitro toxicity testing of crizotinib, sunitinib, erlotinib, and nilotinib in human cardiomyocytes. , 2013, Toxicology and applied pharmacology.
[132] Michael D. Pluth,et al. Identification and Rescue of α-Synuclein Toxicity in Parkinson Patient–Derived Neurons , 2013, Science.
[133] R. Martinez,et al. A cellular model for sporadic ALS using patient-derived induced pluripotent stem cells , 2013, Molecular and Cellular Neuroscience.
[134] H. Deng,et al. Pluripotent Stem Cells Induced from Mouse Somatic Cells by Small-Molecule Compounds , 2013, Science.
[135] S. Moon,et al. Inhibition of pluripotent stem cell-derived teratoma formation by small molecules , 2013, Proceedings of the National Academy of Sciences.
[136] N. McMahon,et al. Comparison of electrophysiological data from human-induced pluripotent stem cell-derived cardiomyocytes to functional preclinical safety assays. , 2013, Toxicological sciences : an official journal of the Society of Toxicology.
[137] I. Weissman,et al. Tumorigenicity as a clinical hurdle for pluripotent stem cell therapies , 2013, Nature Medicine.
[138] Christopher M. Vockley,et al. RNA-guided gene activation by CRISPR-Cas9-based transcription factors , 2013, Nature Methods.
[139] Takanori Takebe,et al. Vascularized and functional human liver from an iPSC-derived organ bud transplant , 2013, Nature.
[140] J. Keith Joung,et al. High frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells , 2013, Nature Biotechnology.
[141] Y. Sasai. Next-generation regenerative medicine: organogenesis from stem cells in 3D culture. , 2013, Cell stem cell.
[142] N. Fujii,et al. Efficient and Reproducible Myogenic Differentiation from Human iPS Cells: Prospects for Modeling Miyoshi Myopathy In Vitro , 2013, PloS one.
[143] Katsuhiro Yoshikawa,et al. Modeling Alzheimer's disease with iPSCs reveals stress phenotypes associated with intracellular Aβ and differential drug responsiveness. , 2013, Cell stem cell.
[144] Torsten Kluba,et al. Genetic correction of a LRRK2 mutation in human iPSCs links parkinsonian neurodegeneration to ERK-dependent changes in gene expression. , 2013, Cell stem cell.
[145] Zhong Zhong,et al. Prevention of β-amyloid induced toxicity in human iPS cell-derived neurons by inhibition of Cyclin-dependent kinases and associated cell cycle events. , 2013, Stem cell research.
[146] Seung Woo Cho,et al. Targeted genome engineering in human cells with the Cas9 RNA-guided endonuclease , 2013, Nature Biotechnology.
[147] James E. DiCarlo,et al. RNA-Guided Human Genome Engineering via Cas9 , 2013, Science.
[148] O. Yanuka,et al. Selective elimination of human pluripotent stem cells by an oleate synthesis inhibitor discovered in a high-throughput screen. , 2013, Cell stem cell.
[149] Le Cong,et al. Multiplex Genome Engineering Using CRISPR/Cas Systems , 2013, Science.
[150] Jennifer Doudna,et al. RNA-programmed genome editing in human cells , 2013, eLife.
[151] Yoshiki Sasai,et al. Cytosystems dynamics in self-organization of tissue architecture , 2013, Nature.
[152] R. Vaughan,et al. Strategy for the creation of clinical grade hESC line banks that HLA-match a target population , 2012, EMBO molecular medicine.
[153] Mark M. Davis,et al. Pluripotent Stem Cells: Immune to the Immune System? , 2012, Science Translational Medicine.
[154] L. Studer,et al. Identification of Compounds that Rescue IKBKAP Expression in Familial Dysautonomia-iPS Cells , 2012, Nature Biotechnology.
[155] Alexander Böcker,et al. Discovery of inhibitors of microglial neurotoxicity acting through multiple mechanisms using a stem-cell-based phenotypic assay. , 2012, Cell stem cell.
[156] H. Okano,et al. Mitochondrial dysfunction associated with increased oxidative stress and α-synuclein accumulation in PARK2 iPSC-derived neurons and postmortem brain tissue , 2012, Molecular Brain.
[157] R. Lahesmaa,et al. Genetic and epigenetic stability of human pluripotent stem cells , 2012, Nature Reviews Genetics.
[158] J. Yates,et al. Progressive degeneration of human neural stem cells caused by pathogenic LRRK2 , 2012, Nature.
[159] J. Doudna,et al. A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity , 2012, Science.
[160] H. Hioki,et al. Drug Screening for ALS Using Patient-Specific Induced Pluripotent Stem Cells , 2012, Science Translational Medicine.
[161] K. Moore,et al. Reprogramming cell fates: insights from combinatorial approaches , 2012, Annals of the New York Academy of Sciences.
[162] Christine Klein,et al. Pharmacological Rescue of Mitochondrial Deficits in iPSC-Derived Neural Cells from Patients with Familial Parkinson’s Disease , 2012, Science Translational Medicine.
[163] N. Benvenisty,et al. Expanding the boundaries of embryonic stem cells. , 2012, Cell stem cell.
[164] Yoshiki Sasai,et al. Self-formation of optic cups and storable stratified neural retina from human ESCs. , 2012, Cell stem cell.
[165] S. Yamanaka. Induced pluripotent stem cells: past, present, and future. , 2012, Cell stem cell.
[166] M. Memo,et al. Disease-specific phenotypes in dopamine neurons from human iPS-based models of genetic and sporadic Parkinson's disease , 2012, EMBO molecular medicine.
[167] Zhen Yan,et al. Parkin controls dopamine utilization in human midbrain dopaminergic neurons derived from induced pluripotent stem cells , 2012, Nature Communications.
[168] Kristopher L. Nazor,et al. Probing sporadic and familial Alzheimer’s disease using induced pluripotent stem cells , 2012, Nature.
[169] H. Okano,et al. [Modeling familial Alzheimer's disease with induced pluripotent stem cells]. , 2012, Rinsho shinkeigaku = Clinical neurology.
[170] Takao Hayakawa,et al. Efficient generation of functional hepatocytes from human embryonic stem cells and induced pluripotent stem cells by HNF4α transduction. , 2012, Molecular therapy : the journal of the American Society of Gene Therapy.
[171] Neville E Sanjana,et al. A transcription activator-like effector toolbox for genome engineering , 2012, Nature Protocols.
[172] Andrew P. Feinberg,et al. Donor cell type can influence the epigenome and differentiation potential of human induced pluripotent stem cells , 2011, Nature Biotechnology.
[173] Fred H. Gage,et al. Modelling schizophrenia using human induced pluripotent stem cells , 2011, Nature.
[174] Shinya Yamanaka,et al. Immunogenicity of induced pluripotent stem cells. , 2011, Circulation research.
[175] D. Zheng,et al. RNA-Seq of Human Neurons Derived from iPS Cells Reveals Candidate Long Non-Coding RNAs Involved in Neurogenesis and Neuropsychiatric Disorders , 2011, PloS one.
[176] Patrick A. Lewis,et al. Parkinson's disease induced pluripotent stem cells with triplication of the α-synuclein locus , 2011, Nature communications.
[177] J. Mendell,et al. Astrocytes from Familial and Sporadic ALS Patients are Toxic to Motor Neurons , 2011, Nature Biotechnology.
[178] N. Benvenisty,et al. Epigenetic memory and preferential lineage-specific differentiation in induced pluripotent stem cells derived from human pancreatic islet beta cells. , 2011, Cell stem cell.
[179] Mitsugu Sekimoto,et al. Reprogramming of mouse and human cells to pluripotency using mature microRNAs. , 2011, Cell stem cell.
[180] S. Yamanaka,et al. The Use of Induced Pluripotent Stem Cells in Drug Development , 2011, Clinical pharmacology and therapeutics.
[181] Jun S. Song,et al. Incomplete DNA methylation underlies a transcriptional memory of somatic cells in human iPS cells , 2011, Nature Cell Biology.
[182] Yasuko Matsumura,et al. A more efficient method to generate integration-free human iPS cells , 2011, Nature Methods.
[183] D. Krainc,et al. Mitochondrial Parkin Recruitment Is Impaired in Neurons Derived from Mutant PINK1 Induced Pluripotent Stem Cells , 2011, The Journal of Neuroscience.
[184] Mark M. Davis,et al. Short-term immunosuppression promotes engraftment of embryonic and induced pluripotent stem cells. , 2011, Cell stem cell.
[185] Blake Byers,et al. LRRK2 mutant iPSC-derived DA neurons demonstrate increased susceptibility to oxidative stress. , 2011, Cell stem cell.
[186] Jarrett Rosenberg,et al. Single cell transcriptional profiling reveals heterogeneity of human induced pluripotent stem cells. , 2011, The Journal of clinical investigation.
[187] Elizabeth E. Hoskins,et al. Directed differentiation of human pluripotent stem cells into intestinal tissue in vitro , 2010, Nature.
[188] Alexander Meissner,et al. Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA. , 2010, Cell stem cell.
[189] Erin L. Doyle,et al. Targeting DNA Double-Strand Breaks with TAL Effector Nucleases , 2010, Genetics.
[190] Deepak M. Gupta,et al. A nonviral minicircle vector for deriving human iPS cells , 2010, Nature Methods.
[191] M. Hasegawa,et al. Efficient induction of transgene-free human pluripotent stem cells using a vector based on Sendai virus, an RNA virus that does not integrate into the host genome , 2009, Proceedings of the Japan Academy. Series B, Physical and biological sciences.
[192] R. Jaenisch,et al. Efficient targeting of expressed and silent genes in human ESCs and iPSCs using zinc-finger nucleases , 2009, Nature Biotechnology.
[193] A. Viale,et al. Modeling Pathogenesis and Treatment of Familial Dysautonomia using Patient Specific iPSCs , 2009, Nature.
[194] Hideyuki Okano,et al. Variation in the safety of induced pluripotent stem cell lines , 2009, Nature Biotechnology.
[195] Prashant Mali,et al. Gene targeting of a disease-related gene in human induced pluripotent stem and embryonic stem cells. , 2009, Cell stem cell.
[196] Robert Lanza,et al. Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins. , 2009, Cell stem cell.
[197] R. Stewart,et al. Human Induced Pluripotent Stem Cells Free of Vector and Transgene Sequences , 2009, Science.
[198] Wei Wang,et al. piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells , 2009, Nature.
[199] Kai Chen,et al. Noninvasive de novo imaging of human embryonic stem cell-derived teratoma formation. , 2009, Cancer research.
[200] James A. Thomson,et al. Induced pluripotent stem cells from a spinal muscular atrophy patient , 2009, Nature.
[201] F. Gage,et al. Non-cell-autonomous effect of human SOD1 G37R astrocytes on motor neurons derived from human embryonic stem cells. , 2008, Cell stem cell.
[202] J. Utikal,et al. Induced Pluripotent Stem Cells Generated Without Viral Integration , 2008, Science.
[203] Donald C. Chang,et al. Mir-302 reprograms human skin cancer cells into a pluripotent ES-cell-like state. , 2008, RNA.
[204] Rutger-Jan Swijnenburg,et al. Immunosuppressive therapy mitigates immunological rejection of human embryonic stem cell xenografts , 2008, Proceedings of the National Academy of Sciences.
[205] R. Hawley. Does retroviral insertional mutagenesis play a role in the generation of induced pluripotent stem cells? , 2008, Molecular therapy : the journal of the American Society of Gene Therapy.
[206] H. R. Lu,et al. Predicting drug-induced changes in QT interval and arrhythmias: QT-shortening drugs point to gaps in the ICHS7B Guidelines , 2008, British journal of pharmacology.
[207] J. Platt,et al. Immunosuppression by Embryonic Stem Cells , 2008, Stem cells.
[208] B. Thiers. Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors , 2008 .
[209] Russell A. Wilke,et al. Identifying genetic risk factors for serious adverse drug reactions: current progress and challenges , 2008, Nature Reviews Drug Discovery.
[210] Marius Wernig,et al. Treatment of Sickle Cell Anemia Mouse Model with iPS Cells Generated from Autologous Skin , 2007, Science.
[211] Shulan Tian,et al. Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells , 2007, Science.
[212] Luigi Naldini,et al. Gene editing in human stem cells using zinc finger nucleases and integrase-defective lentiviral vector delivery , 2007, Nature Biotechnology.
[213] Hynek Wichterle,et al. Astrocytes expressing ALS-linked mutated SOD1 release factors selectively toxic to motor neurons , 2007, Nature Neuroscience.
[214] Kevin Eggan,et al. Non–cell autonomous effect of glia on motor neurons in an embryonic stem cell–based ALS model , 2007, Nature Neuroscience.
[215] S. Yamanaka,et al. Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined Factors , 2006, Cell.
[216] Jeffrey C. Miller,et al. Highly efficient endogenous human gene correction using designed zinc-finger nucleases , 2005, Nature.
[217] Maya Schuldiner,et al. Characterization of the expression of MHC proteins in human embryonic stem cells , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[218] Fred H. Gage,et al. Astroglia induce neurogenesis from adult neural stem cells , 2002, Nature.
[219] Y. Nakajima,et al. In Vitro Differentiation of Embryonic Stem Cells into Hepatocyte‐Like Cells Identified by Cellular Uptake of Indocyanine Green , 2002, Stem cells.
[220] J. Thomson,et al. Embryonic stem cell lines derived from human blastocysts. , 1998, Science.
[221] T. Munsat,et al. International SMA Consortium Meeting (26–28 June 1992, Bonn, Germany) , 1992, Neuromuscular Disorders.
[222] T. Munsat. International SMA consortium meeting , 1992 .